A research team, led by the University of Texas MD Anderson Cancer Center, has identified a protein signature that predicts ovarian cancer patients’ risk of recurrence, which they hope can be developed into a clinical prognostic test.
A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.
Try GenomeWeb Premium now.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
In PLOS this week: genetic factors associated with facial features, a new mutation that makes individuals more prone to Brugada syndrome, and more.
Nutrigenomic companies offer gene-based diet advice, the Wall Street Journal reports.
Researchers have found a new kind of virus — one that starts out broken up into five parts.
Nature News explores the president's "science legacy."